Search Results
Feb 25, 2026, 06:30 ET Allot Announces Fourth Quarter 2025 Financial Results
69% YoY SECaaS ARR growth in 2025, with strong revenue growth and record profitabilityGuiding for revenue growth acceleration to $113-$117 million in 2026HOD HASHARON, Israel, Feb. 25, 2026 /PRNewswire/
More news about: Allot Ltd.
Feb 24, 2026, 15:53 ET Noma Security Appoints Ted Plumis as VP of Global Channel and Alliances to Accelerate Global Partner Strategy and Programs
major industry players including Exabeam, where he served as Senior Vice President and helped scale the company from pre‑revenue to surpassing $200M ARR and achieving leadership in the Gartner Magic Quadrant. Prior to Exabeam, Plumis led worldwide channel and service provider sales at Imperva, where he
More news about: Noma Security
Feb 24, 2026, 09:01 ET project44 Achieves First Positive Operating Free Cash Flow Quarter with 48% New ARR Growth in Q4
Q4, the company delivered 48% year-over-year growth in new Annual Recurring Revenue (ARR), with multi-year agreements driving 73% of new ARR. For the full fiscal year 2026, project44 achieved 24% year-over-year new ARR growth, signaling deepening customer commitment and growing confidence in its long-term
More news about: project44
Feb 24, 2026, 09:00 ET Contact The Gross Law Firm by March 9, 2026 Deadline to Join Class Action Against Varonis Systems, Inc.(VRNS)
customers on its platform, resulting in significantly reduced ARR growth potential in the near-term. On October 28, 2025, Varonis announced its financial results for the third quarter of fiscal 2025, disclosing a significant miss to ARR and reducing its projections for the full fiscal year 2025, despite
More news about: The Gross Law Firm
Feb 24, 2026, 08:46 ET VRNS Federal Sector Collapse: Hagens Berman Investigating Varonis (VRNS) Over Alleged SaaS Transition Failure and Undisclosed Renewal Softness in Securities Class Action
allegedly suggested to investors. This disclosure, which revealed a 63.9% year-over-year decline in term license revenue and a slashed ARR outlook, triggered a 48% single-day stock crash, wiping out approximately $3.8 billion in market value.The firm urges VRNS investors
More news about: Hagens Berman Sobol Shapiro LLP
Feb 24, 2026, 08:30 ET Cato Networks Surpasses $350 Million ARR with 43% YoY Growth in 2025
Cato Networks, the SASE leader, today announced that its 2025 annual recurring revenue (ARR) surpassed $350 million, an increase of 43% year-over-year (YoY) compared to 2024. Cato is significantly outpacing the SASE market and reinforcing its
More news about: Cato Networks
Feb 24, 2026, 07:09 ET Einride has Divested its Design Organization
statements" within the meaning of U.S. federal securities laws including, but not limited to, statements regarding Einride's expected and potential ARR, as applicable, and the Transaction with Legato. These forward-looking statements generally are identified by the words "believe," "project," "expect,"
More news about: Einride
Feb 24, 2026, 07:02 ET Einride has Divested its Design Organization
statements" within the meaning of U.S. federal securities laws including, but not limited to, statements regarding Einride's expected and potential ARR, as applicable, and the Transaction with Legato. These forward-looking statements generally are identified by the words "believe," "project," "expect,"
More news about: Einride
Feb 24, 2026, 03:00 ET Ikiru People Ltd: Talentis grows 67% in 6 months, as Dillistone Group announces major new investment for 2026
Feb. 24, 2026 /PRNewswire/ -- Talentis – the Executive Search Software with a 4.9* rating on G2, is pleased to announce growth of 67% in exit ARR in H2 of 2025. This dramatic increase in revenue and subscriber numbers likely positions the platform as the fastest growing executive search CRM on
More news about: Ikiru People Ltd
Feb 23, 2026, 00:36 ET VRNS Deadline: VRNS Investors Have Opportunity to Lead Varonis Systems, Inc. Securities Lawsuit
the lawsuit, defendants made materially false and/or misleading statements and or failed to disclose that: (1) Varonis would not be able to maintain ARR projections while converting both its federal and non-federal existing on-prem customers to the software-as-a-service ("SaaS") alternative offering;
More news about: THE ROSEN LAW FIRM, P. A.
Feb 21, 2026, 08:00 ET Non-Narcotic Analgesics Allergy Labels Linked to Adverse Maternal and Fetal Outcomes
were significantly associated with increased rates of eclampsia (aRR 1.5, 95% CI [1.06, 2.12]), preterm birth (aRR 1.21, 95% CI [1.14, 1.28]), NICU admission (aRR 1.17, 95% CI [1.10, 1.25]), infants with neonatal withdrawal syndrome (aRR 1.51, 95% CI [1.24, 1.84]), longer infant hospital stay times (p
More news about: American Academy of Allergy, Asthma & Immunology (AAAAI)
Feb 21, 2026, 03:08 ET CHAI 3X Annual Growth Reaching $70M ARR & Latest AI Safety Update
Over the past three years, we've experienced phenomenal momentum, continuing a 3X annual growth rate to reach $68 million in ARR and achieve a $1.4 billion valuation. With this rapid growth comes an even greater responsibility. Despite the exciting prospects, we recognize the inherent challenges
More news about: Chai Research Corp
Feb 20, 2026, 12:41 ET Hagens Berman Investigating Varonis (VRNS) Over Alleged SaaS Transition Failure and Undisclosed Renewal Softness in Securities Class Action
allegedly suggested to investors. This disclosure, which revealed a 63.9% year-over-year decline in term license revenue and a slashed ARR outlook, triggered a 48% single-day stock crash, wiping out approximately $3.8 billion in market value.The firm urges VRNS investors
More news about: Hagens Berman Sobol Shapiro LLP
Feb 19, 2026, 20:04 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Commvault Systems, Inc. - CVLT
quarter of fiscal 2026 ended December 31, 2025 and revealed "40% growth in SaaS ARR to $364 million," and that "60% of our deals actually closed in the last few weeks of the quarter." According to Bloomberg Intelligence, "SaaS ARR growth of 40% represents a meaningful deceleration from 56%" reported by Commvault
More news about: Pomerantz LLP
Feb 19, 2026, 19:29 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Varonis Systems, Inc. of Class Action Lawsuit and Upcoming Deadlines - VRNS
our full-year ARR guidance to account for the underperformance of [its] on-prem subscription business." On an earnings call the next day, Yakov Faitelson, the Company's Co-Founder, Chairman, CEO & President, stated the on-premises subscription business is a "drag on total company ARR growth." Management
More news about: Pomerantz LLP
Feb 19, 2026, 17:00 ET RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus immunotherapy shows strong clinical benefit with 56 percent overall response rate in first-line recurrent or metastatic head and neck cancer
can cause hypersensitivity and administration-related reactions (ARRs); signs and symptoms of ARR include dyspnea, flushing, fever, chills, chest discomfort, hypotension, and vomiting. The median time to ARR onset is approximately 2 hours.RYBREVANT FASPRO™ with LAZCLUZE®In
More news about: Johnson & Johnson
Feb 19, 2026, 16:02 ET Varonis Systems, Inc. (VRNS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
alleges that, between February 4, 2025 and October 28, 2025, Defendants failed to disclose to investors that: (1) Varonis was ill-equipped to continue its ARR growth trajectory without maintaining a significantly high rate of quarterly conversions; and (2) as a result, Defendants' positive statements about
More news about: Glancy Prongay Wolke & Rotter LLP
Feb 19, 2026, 09:00 ET Abstract Launches AI-Gen Composable SIEM, Redefining the Future of Security Operations
Following 380% ARR growth in 2025, Abstract formalizes the AI-Gen architecture powering modern SOC transformationSAN FRANCISCO, Feb. 19, 2026 /PRNewswire/ -- Abstract, the leader in streaming-first
More news about: Abstract Security Inc
Feb 19, 2026, 09:00 ET Shareholders of Varonis Systems, Inc. Should Contact The Gross Law Firm Before March 9, 2026 to Discuss Your Rights - VRNS
customers on its platform, resulting in significantly reduced ARR growth potential in the near-term. On October 28, 2025, Varonis announced its financial results for the third quarter of fiscal 2025, disclosing a significant miss to ARR and reducing its projections for the full fiscal year 2025, despite
More news about: The Gross Law Firm
Feb 18, 2026, 09:00 ET Varonis Systems, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 9, 2026 to Discuss Your Rights - VRNS
customers on its platform, resulting in significantly reduced ARR growth potential in the near-term. On October 28, 2025, Varonis announced its financial results for the third quarter of fiscal 2025, disclosing a significant miss to ARR and reducing its projections for the full fiscal year 2025, despite
More news about: Levi & Korsinsky, LLP
Feb 18, 2026, 08:54 ET VRNS Federal Sector Collapse: Hagens Berman Investigating Varonis (VRNS) Over Alleged SaaS Transition Failure and Undisclosed Renewal Softness in Securities Class Action
allegedly suggested to investors. This disclosure, which revealed a 63.9% year-over-year decline in term license revenue and a slashed ARR outlook, triggered a 48% single-day stock crash, wiping out approximately $3.8 billion in market value.The firm urges VRNS investors
More news about: Hagens Berman Sobol Shapiro LLP
Feb 18, 2026, 08:05 ET Selector Raises $32 Million to Eliminate Downtime with AI-Powered Observability
product innovation, with key milestones such as:Cumulative annual recurring revenue (ARR) reached 230% of 2024 levels, marking the fourth year the company doubled ARRNew ARR booked reached 370% of 2024, driven by accelerating enterprise demandAdded three new Fortune
More news about: Selector
Feb 18, 2026, 08:00 ET Ambient.ai Doubles New Annual Recurring Revenue as Agentic Physical Security Reaches Inflection Point
The pioneer of agentic physical security reports doubling of New ARR added and 140%+ net revenue retention as its customer base triples since the launch of Ambient Intelligence and reasoning Visual Language Models for physical securityREDWOOD
More news about: Ambient.ai
Feb 18, 2026, 07:30 ET RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer
can cause hypersensitivity and administration-related reactions (ARRs); signs and symptoms of ARR include dyspnea, flushing, fever, chills, chest discomfort, hypotension, and vomiting. The median time to ARR onset is approximately 2 hours.RYBREVANT FASPRO™ with LAZCLUZE®In
More news about: Johnson & Johnson
Feb 18, 2026, 05:00 ET Trend Micro Reports Earnings Results for Q4 2025 and FY 2025
with enterprise ARR up 2%, surpassing $1.3B***. Platform adoption and expansion continues to propel sales as enterprises seek tool consolidation and proactive security to manage risk and remain ahead of accelerating AI-driven cyber threats. Up 58% in Q4, large enterprise platform ARR reached $467M*,
More news about: Trend Micro Incorporated